Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned? by Yee, L J
REVIEW
Understanding correlates of hepatitis B virus vaccination
in men who have sex with men: what have we learned?
L J Yee, S D Rhodes
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sex Transm Infect 2002;78:374–377
Objectives: Hepatitis B infection (HBV) is prevalent among men who have sex with men (MSM) and
may lead to significant morbidity and death. Although an effective vaccine exists vaccination rates
among MSM are low. We conducted a systematic review to synthesise the various findings from
empirical correlational studies to understand HBV vaccination and series completion among MSM.
Methods: We systematically searched the Medline, PubMed, EMBASE, CINAHL, ERIC, and Web of
Science databases to identify the breadth of published studies pertaining to HBV vaccination among
MSM and to synthesise findings from these studies to better identify common themes that may direct
future research and intervention approaches.
Results: Eight papers specifically addressed correlates of HBV vaccination among MSM. Six domains
were identified as predictors of vaccination: (1) demographic variables such as younger age and
higher education level; (2) knowledge of the vaccine; (3) access to health care; (4) level of “outness”
regarding one’s same sex sexual orientation; (5) behavioural factors including sexual and drug use
behaviour; and (6) psychosocial variables. Three papers addressed predictors of vaccine series com-
pletion among MSM, observing two main domains: (1) demographic variables such as younger age
and higher income level; and, (2) behavioural factors including sexual and health promotion
behaviours.
Conclusions: Continued educational efforts, creation of environments that facilitate proper risk factor
evaluation, and access to low cost vaccine may facilitate vaccine uptake. Although we observed
important trends in the studies we reviewed, there is a lack of empirical research regarding this impor-
tant public health issue.
Hepatitis B virus (HBV) infection remains one of themost important public health issues facing men whohave sex with men (MSM),1–5 and MSM comprise a sig-
nificant proportion of new HBV infections.6 7 Population based
studies specifically examining HBV infection in MSM have
consistently shown high levels of serological markers indica-
tive of past or persistent HBV infection.8–10
Since 1982, an effective, three dose vaccine against HBV has
been available. Yet two decades after introduction of the HBV
vaccine, studies continue to show that vaccination rates are
low among MSM.8 10–14 Unfortunately little is known about
why some MSM obtain the vaccine and others do not,15 and
why some men who start the vaccine series complete it, and
others do not.16
We synthesised the published research literature to identify
common findings, themes, and trends related to HBV vaccina-
tion uptake and vaccine series completion among MSM in
order to better inform vaccination programmes targeting this
population. Based on our review, we also identified research
gaps and needs.
METHODS
We conducted a systematic review of English language publi-
cations pertaining to hepatitis B vaccination using the
Medline and Web of Science databases, 1966 through May
2002, and ERIC, CINAHL, PubMed, and EMBASE, 1980
through February 2002, to identify research papers related to
HBV vaccination among MSM. A systematic series of keyword
and subject searches were conducted, firstly, to identify
articles concerning hepatitis B vaccination and then to
identify articles concerning men who engage in same sex
sexual behaviour, including self identified and non-self iden-
tified homosexual men. Subsequently, combinations of the
two search results were used to identify papers specifically
addressing correlates of HBV vaccination in MSM. In addition,
citations from the bibliographies of these articles were
analysed and relevant citations were selected for review as
well. We restricted our review to adult MSM.
RESULTS
Correlates of vaccination
Our literature search yielded eight papers directly addressing
correlates of HBV vaccination among MSM. Seven of the
papers reported multivariable correlations,2 11 17–21 and one
paper reported univariable correlations exclusively.22
To summarise, six domains associated with HBV vaccina-
tion were identified in the current HBV vaccination literature
(table 1). The first domain included demographic variables
that have been reported to be predictive of HBV vaccination,
including younger age;11 19 school attendance or higher level of
education;11 17 22 living in an urban setting;2 and professional
medical training.19
The next domain included participant knowledge of HBV
and of the vaccine. Knowledge was associated with vaccina-
tion in three separate studies.18 19 22
Access to health care was identified as the third domain
associated with vaccination in two studies through two meas-
ures, including having a regular source of health care, and
having health insurance.11 22
Openness or the level of “outness” about one’s same sex
sexual orientation and one’s risk behaviours with healthcare
providers and others was the fourth domain identified to be
associated with vaccination.2 11 19
The fifth domain was characterised by behavioural corre-
lates of vaccination. These included homosexual behaviour,20
health promotion behaviours such as condom use,18 limited
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numbers of lifetime sexual partners,2 never having injected
drugs,2 testing for HIV,11 and having had sex in a bathhouse
within the past 6 months.2
The psychosocial correlates of HBV vaccination were
explored in one study and comprise the sixth and final domain
identified to explain HBV vaccination among MSM.21 Al-
though not measuring correlates of vaccination directly, this
study found three psychosocial variables to predict intention
to be vaccinated, including attitude towards vaccination; social
norms surrounding vaccination; and perceived vulnerability to
HBV infection.
Correlates of vaccine series completion
Three papers were identified that explored correlates of
vaccine series completion among MSM. Two domains associ-
ated with HBV vaccine series completion were identified based
on the current review (table 2). The first domain included
demographic variables that have been reported to be
predictive of HBV vaccine series completion including older
age23 and higher income.2
The second domain was characterised by behavioural corre-
lates of vaccine series completion including MSM
behaviour;20 health promotion behaviours,2 such as not
exchanging sex for goods, services or drugs, and protected
anal sex with regular partners during the previous 6 months;
and sexual risk behaviours2 such as higher numbers of lifetime
partners, a history of STD infection, and alcohol use before
engaging in sexual intercourse.
DISCUSSION
Our review suggests that several factors may be used to facili-
tate vaccine uptake in MSM populations. Firstly, the continu-
ation of educational efforts, including social marketing
campaigns promoting HBV vaccination among MSM, should
be encouraged and new strategies further developed. Sec-
ondly, creating healthcare environments conducive to proper
disclosure and assessment of an individual’s risk for HBV
should be fostered. Thirdly, access to low cost vaccine and,
indirectly, access to medical care must be strengthened.
The observed correlations between increased knowledge of
HBV infection and vaccination in several studies18 19 22 may
reflect the success of educational and social marketing
campaigns targeting this risk group.24 The association that
MSM were more likely to start the vaccine series than hetero-
sexuals may reflect this assumption.20 Similarly, the higher
reported vaccination rates in younger MSM,11 19 as well as
those with more education,11 probably reflect enhanced efforts
in some countries such as the United States to educate
younger populations and provide vaccine for adolescents
including young MSM.25 26
However, it is evident that these messages have not reached
all members of this community, as some studies showed that
Table 1 Summary of statistically significant (p<0.05) correlates of HBV vaccination
among MSM. Part A lists factors positively correlated with vaccination, while part B




Younger age 11, 19
Education (currently attending school or having a higher level of education) 11, 17, 22
Living in an urban setting 2
Professional (health related) training 19
Vaccine knowledge
Knowledge of HBV vaccine 18, 19, 22
Access to health care
Having regular source of health care 22, 11
Having health insurance 22, 11
Sexual orientation
Openness (“outness”) about one’s same sex sexual orientation with healthcare providers 19, 2
Openness (“outness”) about one’s same sex sexual orientation in general 11
Behavioural correlates
Homosexual (versus hetersexual) behaviour 20
Health promotion behaviours (ie, condom use) 18
Limited number of lifetime sexual partners 2
Never having injected drugs 2
HIV or HBV testing 11, 17
Psychosocial correlates
Attitude towards vaccination 21
Social norms surrounding vaccination 21
Perceived vulnerability to HBV infection 21
B Negative correlates
Behavioural correlates
>20 lifetime sexual partners 2
Injection drug use 2
Psychosocial correlates
Perceived high cost of the vaccine 22
Perception of being “low risk” for HBV 22
Table 2 Summary of statistically significant (p<0.05)
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up to 33% of MSM reported knowing nothing about HBV or
HBV vaccination18 19 22; thus, an added emphasis on innovative
educational efforts may be necessary to raise the awareness of
HBV and HBV vaccination in broader demographic groups,
with more subgroups of the MSM community specifically tar-
geted during campaigns—for example, older MSM who are
less likely to be vaccinated.11 19 The creative use of innovative
messages and channels for message delivery must be
explored. Although peer education through lay health adviser
networks within the MSM community has proved to be an
effective method to reach MSM for HIV prevention,27 this has
not been tested empirically for the promotion of hepatitis B
vaccination.
Secondly, our review also highlights the importance of
communication between healthcare providers and their
patients about risk for HBV infection. In particular, open com-
munication about sexual orientation may play an important
part in promoting vaccination of some MSM.2 11 19 Healthcare
providers have an important role in facilitating vaccination
and creating an environment in which open communication
about risk can occur. Studies have shown in other populations
that recommendation by a healthcare provider is a strong pre-
dictor of preventive behaviour.28 29 Thus, healthcare providers
may have the potential to positively impact HBV vaccination
among MSM in both privately and publicly funded healthcare
facilities.
Studies of HBV vaccination rates in sexually transmitted
disease (STD) clinics suggest that HBV vaccination rates of
clinic patients are low.13 30 Because individuals being treated
for STD would be considered at high risk for HBV infection,1
not vaccinating this group is indeed a missed opportunity to
prevent disease. This approach of vaccinating high risk
individuals as they present to health providers has been previ-
ously recommended and may be an effective way of targeting
such individuals.31 32 Further research is needed to understand
whether STD client patients are being offered HBV vaccina-
tion, and if they are being offered vaccination services, why
some patients are choosing to remain unvaccinated.
Lastly, some individuals believe that HBV vaccine is
financially costly and this perception may hinder their desire
to seek vaccination; 29% of MSM in a Boston community
health centre surveyed reported that they would like to be
vaccinated against HBV but were deterred by the perceived
high cost of the vaccination.22 Thus, offering the vaccine free or
at reduced cost may increase vaccination rates. Even some
healthcare providers cite cost as a major deterrent for
vaccination.33 However, even among individuals with health
insurance, a lack of knowledge exists among some about
whether their insurance covers the costs of HBV
vaccination.12 Simultaneously educating healthcare providers
about proper insurance reimbursement practices may also
help those countries where private insurance is an important
healthcare factor. Thus, aggressively increasing general access
to vaccination services through reduced cost, the use of offsite
clinic vaccination services, and educating individuals about
their insurance coverage may help improve vaccine uptake. For
vaccinating individuals who are uninsured, access to free or
low cost vaccinations will be a key factor.
Correlates of vaccine series completion
The understanding of correlates of vaccine series completion is
less clear. In a study by Dufour, a strong correlation was found
between failure to complete the series and high risk
behaviours such as unprotected intercourse or the trading sex
for drugs, goods, or services.2 Low risk sexual behaviours as
reflected in never having had an STD or fewer than 20 lifetime
sexual partners, on the other hand, were correlated with series
completion.2 Possibly, MSM who trade sex for drugs have lim-
ited access to, or discontinuity of, care or simply opt to not
seek care or follow through when multiple visits to a
healthcare provider are necessitated. Again, a combination of
creative social marketing; improved provider skills in assessing
and encouraging vaccination; and increased access to vaccina-
tion services through financial subsidy and untraditional off-
site clinic vaccination sites may be necessary to reach these
hard to reach, yet most vulnerable, individuals. Clearly, other
factors affect vaccine series completion, and these should be
further explored in future studies.
Concluding comments
We have attempted to highlight trends in the current research
to better inform future HBV vaccination efforts among MSM
and draw together results of several studies on an important
public health topic for which a paucity of empirical
information exists. We synthesised findings and highlighted
possible commonalities and explanations among them.
During the 1980s a wealth of research regarding the HBV vac-
cine was conducted. While most studies focused on the
biological aspects such as vaccine immunogenicity, little focus
was placed on identifying behavioural targets for improve-
ment of vaccine uptake. Future studies should systematically
and empirically evaluate the trends we have identified.
Vaccination behaviour is complex and requires a multilevel
approach both when trying to understand and affect
behaviour. In order to reach MSM, a social ecological approach
may be an effective framework to use to increase vaccination
against HBV among MSM.34 The dynamic interplay among
factors at the intrapersonal, interpersonal, institutional, com-
munity, and public policy levels requires multilevel interven-
tion strategies. However, more research is needed to fully
understand predictors of vaccination and vaccine completion
within all levels.
A tremendous and fundamental gap in the HBV vaccination
literature concerns the populations studied. In all of the
papers that met our inclusion criteria, the populations studied
were predominantly white. There is an urgent need for further
studies to include other racial groups to better understand
possible cultural differences in vaccine seeking knowledge,
attitudes, beliefs, and behaviours, especially with respect to
the fact that some racial/ethnic groups, such as black people
and Asians in the United States, have a higher incidence and
prevalence of HBV.35–37
After 20 years of vaccine availability, much is still unknown.
Laboratory science has developed and provided an effective
vaccine; behavioural science must now provide the strategies
to increase vaccination rates, while public health must provide
the infrastructure to create enduring positive influences on
this important health issue.
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Key messages
• Additional educational efforts to promote HBV vaccination
must be encouraged
• Environments conducive to proper risk disclosure/
assessment are needed
• Availability of low cost/free vaccines are important




. . . . . . . . . . . . . . . . . . . . .
Authors’ affiliations
L J Yee, Infectious Disease Epidemiology Unit, London School of Hygiene
and Tropical Medicine, Department of Infectious and Tropical Diseases,
Keppel Street, London WC1E 7HT, UK
S D Rhodes, Department of Health Behavior and Health Education,
University of North Carolina School of Public Health, 319D Rosenau
Hall, CB# 7440, Chapel Hill, NC 27599-7440, USA
REFERENCES
1 Centers for Disease Control and Prevention. Hepatitis B: a
comprehensive strategy for eliminating transmission in the United States
through universal childhood vaccination. Recommendations of the
Immunization Practices Advisory Committee (ACIP). MMWR
1991;40((RR-13)):1–25.
2 Dufour A, Remis RS, Alary M, et al. Factors associated with hepatitis B
vaccination among men having sexual relations with men in Montreal,
Quebec, Canada. Omega Study Group. Sex Transm Dis
1999;26:317–24.
3 Kane M. Epidemiology of hepatitis B infection in North America.
Vaccine 1995;13(Suppl 1):S16–17.
4 Kingsley LA, Rinaldo CR, Lyter DW, et al. Sexual transmission efficiency
of hepatitis B virus and human immunodeficiency virus among
homosexual men. JAMA 1990;264:230–4.
5 Institute of Medicine. Committee on Prevention and Control of Sexually
Transmitted Diseases. The hidden epidemic: confronting sexually
transmitted diseases. Washington, DC: National Academy Press, 1997.
6 Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B:
2000—summary of a workshop. Gastroenterology 2001;120:1828–53.
7 Mast EE, Williams IT, Alter MJ, et al. Hepatitis B vaccination of
adolescent and adult high-risk groups in the United States. Vaccine
1998;16(Suppl):S27–9.
8 Remis RS, Dufour A, Alary M, et al. Association of hepatitis B virus
infection with other sexually transmitted infections in homosexual men.
Omega Study Group. Am J Public Health 2000;90:1570–4.
9 Anderson B, Bodsworth NJ, Rohrsheim RA, et al. Hepatitis B virus
infection and vaccination status of high risk people in Sydney: 1982 and
1991. Med J Aust 1994;161:368–71.
10 Silvestre AJ, Kingsley LA, Wehman P, et al. Changes in HIV rates and
sexual behavior among homosexual men, 1984 to 1988/92. Am J
Public Health 1993;83:578–80.
11 MacKellar DA, Valleroy LA, Secura GM, et al. Two decades after
vaccine license: hepatitis B immunization and infection among young
men who have sex with men. Am J Public Health 2001;91:965–71.
12 Centers for Disease Control and Prevention. Undervaccination for
hepatitis B among young men who have sex with men—San Francisco
and Berkeley, California, 1992–1993. MMWR 1996;45:215–17.
13 Bhatti N, Gilson RJ, Beecham M, et al. Failure to deliver hepatitis B
vaccine: confessions from a genitourinary medicine clinic. BMJ
1991;303:97–101.
14 Goldberg D, McMenamin J. The United Kingdom’s hepatitis B
immunisation strategy–where now? Commun Dis Public Health
1998;1:79–83.
15 McDonnell WM, Askari FK. Immunization. JAMA 1997;278:2000–7.
16 Sellors J, Pickard L, Mahony JB, et al. Understanding and enhancing
compliance with the second dose of hepatitis B vaccine: a cohort analysis
and a randomized controlled trial. CMAJ 1997;157:143–8.
17 Neighbors K, Oraka C, Shih L, et al. Awareness and utilization of the
hepatitis B vaccine among young men in the Ann Arbor area who have
sex with men. J Am Coll Health 1999;47:173–8.
18 Rhodes S, DiClemente RJ, Yee LJ, et al. Hepatitis B vaccination in a high
risk MSM population: the need for vaccine education. Sex Transm Infect
2000;76:408–9.
19 Rhodes SD, DiClemente RJ, Yee LJ, et al. Correlates of hepatitis B
vaccination in a high-risk population: an internet sample. Am J Med
2001;110:628–32.
20 Savage RB, Hussey MJ, Hurie MB. A successful approach to immunizing
men who have sex with men against hepatitis B. Public Health Nurs
2000;17:202–6.
21 Schutten M, de Wit JB, van Steenbergen JE. Why do gay men want to
be vaccinated against hepatitis B? An assessment of psychosocial
determinants of vaccination intention. Int J STD AIDS 2002;13:86–90.
22 McCusker J, Hill EM, Mayer KH. Awareness and use of hepatitis B
vaccine among homosexual male clients of a Boston community health
center. Public Health Rep 1990;105:59–64.
23 Yuan L, Robinson G. Hepatitis B vaccination and screening for markers
at a sexually transmitted disease clinic for men. Can J Public Health
1994;85:338–41.
24 Gay and Lesbian Medical Association. GLMA National Campaign
launched 20 January 2001: http://glma.org/hepatitis/index.html.
25 Centers for Disease Control and Prevention. Update:
recommendations to prevent hepatitis B virus transmission—United States.
MMWR 1999;48:33–4.
26 Centers for Disease Control and Prevention. Update:
recommendations to prevent hepatitis B virus transmission-United States.
MMWR 1995;44:574–5.
27 Kelly JA. HIV prevention interventions with gay or bisexual men and
youth. AIDS 2000;14(Suppl 2):S34–9.
28 Goldstein M, DePue J, Kazura A, et al. Models for provider-patient
interaction: applications to health behavior change. In: Shumaker SA,
Schron EB, Ockene JK, et al. eds. The handbook of health behavior
change. New York: Springer, 1998:85–113.
29 Royce RA, Walter EB, Fernandez MI, et al. Barriers to universal prenatal
HIV testing in 4 US locations in 1997. Am J Public Health
2001;91:727–33.
30 Rabeneck L, Risser JM, Murray NG, et al. Failure of providers to
vaccinate HIV-infected men against hepatitis B: a missed opportunity. Am
J Gastroenterol 1993;88:2015–8.
31 Jones TS, Margolis HS. One stop shopping: integrating prevention
services for viral hepatitis. Paper presented at the 10th International
Symposium on Viral Hepatitis and Liver Disease 2000; Atlanta, Georgia,
April 2000.
32 Gunn RA, Murray PJ, Ackers ML, et al. Screening for chronic hepatitis B
and C virus infections in an urban sexually transmitted disease clinic:
rationale for integrating services. Sex Transm Dis 2001;28:166–70.
33 Sharfstein J, Wise PH. Inadequate hepatitis B vaccination of adolescents
and adults at an urban community health center. J Natl Med Assoc
1997;89:86–92.
34 Sallis J, Oven N. Ecological Models. In: Glanz K, Lewis F, eds. Health
behavior and education:theory, research and practice. 2nd ed. San
Francisco: Jossey-Bass, 1996:403–24.
35 McQuillan GM, Coleman PJ, Kruszon-Moran D, et al. Prevalence of
hepatitis B virus infection in the United States: the national health and
nutrition examination surveys, 1976 through 1994. Am J Pub Health
1999;89:14–18.
36 Coleman PJ, McQuillan GM, Moyer LA, et al. Incidence of hepatitis B
virus infection in the United States, 1976–1994: estimates from the
national health and nutrition examination surveys. J Infect Dis
1998;178:954–9.
37 Siegel D, Alter MJ, Morse S. Hepatitis B virus infection in high-risk
inner-city neighborhoods in San Francisco. Hepatology 1995;22:44–9.
Hepatitis B vaccination 377
www.sextransinf.com
